Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Study of UFT+ Leucovorin (L) Given as a Three Times Daily (TID) Regimen in the Treatment of Patients (Pts) with Metastatic Breast Cancer (MBC)

Rivera E, Hyzinski M, Hutchins LF, Booser D, Mason B, Hortobagyi G. A Study of UFT+ Leucovorin (L) Given as a Three Times Daily (TID) Regimen in the Treatment of Patients (Pts) with Metastatic Breast Cancer (MBC). 2001.